申请人:Hoechst Aktiengesellschaft
公开号:US05204357A1
公开(公告)日:1993-04-20
The invention relates to compounds of the formula I ##STR1## in which A represents a substituted thio-, sulfinyl- or sulfonyl-alkanoyl radical or a four- to eleven-membered heterocycle, B is an amino acid residue, R.sup.1 denotes hydrogen (substituted) alkyl, (substituted)cycloalkyl or aryl, R.sup.2 represents hydrogen, (substituted)alkyl or aryl, R.sup.3 denotes a radical of the formula --(CH.sub.2).sub.q --(X).sub.r --(CH.sub.2).sub.s --R.sup.6 with X denoting CF.sub.2, CO or CHR.sup.8, R.sup.6 denoting a (substituted)heteroaromatic, R.sup.8 denoting alkyl, alkoxy, alkylthio, alkylamino, hydroxyl, azide or halogen, q and s denoting 1 to 4, and r denoting 0 or 1, and R.sup.9 is hydrogen, (substituted)alkyl, alkanoyl, cycloalkanoyl, (substituted) aroyl or (substituted)aryl, and to the salts thereof. In addition, processes for the preparation of these compounds, and the use thereof as renin inhibitors are described.
该发明涉及以下式I的化合物:其中A代表取代的
硫、亚
硫酰或磺酰-烷酰基团或四元至十一元杂环,B是
氨基酸残基,R.sup.1表示
氢(取代)烷基、(取代)
环烷基或芳基,R.sup.2表示
氢、(取代)烷基或芳基,R.sup.3表示--(CH.sub.2).sub.q --(X).sub.r --(CH.sub.2).sub.s --R.sup.6的基团,其中X表示CF.sub.2、CO或CHR.sup.8,R.sup.6表示(取代)杂芳基,R.sup.8表示烷基、烷
氧基、烷
硫基、烷基
氨基、羟基、
叠氮基或卤素,q和s表示1至4,r表示0或1,R.sup.9为
氢、(取代)烷基、烷酰基、
环烷酰基、(取代)芳酰基或(取代)芳基,以及其盐。此外,描述了这些化合物的制备方法和它们作为肾素
抑制剂的用途。